AC Immune S.A. (ACIU)
NASDAQ·Healthcare·Biotechnology
$2.37
+6.28%
Mkt Cap $287.72M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
Implied Upside
+251.5%
Consensus $8.33 vs current $2.37
NASDAQ·Healthcare·Biotechnology
$2.37
+6.28%
Mkt Cap $287.72M
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
+251.5%
Consensus $8.33 vs current $2.37